BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9082673)

  • 21. [Radiofrequency ablation in the treatment of tachyarrhythmias. Experience concerning 1,000 consecutive patients].
    Iturralde-Torres P; Colín-Lizalde L; Kershenovich S; González-Hermosillo JA
    Gac Med Mex; 1999; 135(6):559-75. PubMed ID: 10605256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Para' AV nodal re-entry tachycardias.
    Hauer RN; Loh P
    Eur Heart J; 1998 May; 19 Suppl E():E2-9, E46-7. PubMed ID: 9717018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation in a patient with atrioventricular reentrant tachycardia and atrioventricular nodal reentrant tachycardia with 2:1 atrioventricular block.
    Oliveira M; de Ponti R; Trito M; Spadacini G; Uriarte JS
    Rev Port Cardiol; 2002 Nov; 21(11):1319-26. PubMed ID: 12564083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of slow pathway ablation in atrioventricular nodal reentrant tachycardia on the electrophysiologic characteristics of the inferior atrial inputs to the human atrioventricular node.
    Katritsis DG; Becker AE; Ellenbogen KA; Giazitzoglou E; Korovesis S; Camm AJ
    Am J Cardiol; 2006 Mar; 97(6):860-5. PubMed ID: 16516590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pacing site and bradycardia dependent retrograde conduction block over an atrioventricular accessory pathway.
    Bai R; Tritto M; Di Biase L; Salerno-Uriarte JA
    Europace; 2006 Jun; 8(6):438-42. PubMed ID: 16648245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway].
    Fassini G; Riva S; Della Bella P; Carbucicchio C; Tondo C
    Cardiologia; 1996 Sep; 41(9):869-75. PubMed ID: 8983843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience in 1,500 patients undergoing radiofrequency ablation in the treatment of tachycardias].
    Iturralde Torres P; Colín Lizalde L; Guevara Valdivia M; Rodríguez Chávez L; Kershenovich Shapiro S
    Arch Inst Cardiol Mex; 2000; 70(4):349-66. PubMed ID: 11075281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pacemaker-like syndrome complicating slow pathway ablation for AV nodal reentrant tachycardia.
    Toal S; Chauhan VS
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):997-9. PubMed ID: 16176544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Administration of adenosine for termination of atrioventricular nodal reentry tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway and unmasking of concomitant Wolff-Parkinson-White syndrome].
    Drescher S; Bosch RF; Mewis C; Kühlkamp V
    Z Kardiol; 2000 Jun; 89(6):522-6. PubMed ID: 10929437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncontact three-dimensional mapping guides catheter ablation of difficult atrioventricular nodal reentrant tachycardia.
    Lee PC; Tai CT; Lin YJ; Liu TY; Huang BH; Higa S; Yuniadi Y; Lee KT; Hwang B; Chen SA
    Int J Cardiol; 2007 May; 118(2):154-63. PubMed ID: 17023073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraprocedural predictors of successful ablation of slow pathway for atrioventricular nodal reentrant tachycardia.
    Dobreanu D; Micu S; Toma O; Rudzik R
    Rom J Intern Med; 2007; 45(1):35-46. PubMed ID: 17966441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concealed conduction and dual pathway physiology of the atrioventricular node.
    Liu S; Olsson SB; Yang Y; Hertervig E; Kongstad O; Yuan S
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):144-9. PubMed ID: 15028041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of clinical and electrophysiologic characteristics of patients with occult and manifest atrioventricular accessory pathway].
    Bottoni N; Donateo P; Tomasi C; Lolli G; Oddone D; Croci F; Menozzi C; Brignole M
    Ital Heart J Suppl; 2001 Aug; 2(8):888-93. PubMed ID: 11582721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency catheter ablation of two accessory pathways with different unidirectional conduction properties.
    Rostock T; Lutomsky B; Ventura R; Meinertz T; Willems S
    Z Kardiol; 2005 May; 94(5):343-7. PubMed ID: 15868363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter ablation of atrioventricular nodal reentrant tachycardia and bypass-tract mediated tachycardias.
    Orias DW; Calkins H
    Coron Artery Dis; 1996 Jan; 7(1):5-11. PubMed ID: 8773427
    [No Abstract]   [Full Text] [Related]  

  • 37. Wide QRS-complex tachycardia with variable VA-conduction: what is the mechanism?
    Tanner H; Sakata T; Delacrétaz E
    Europace; 2008 Jan; 10(1):110-1. PubMed ID: 18006558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adenosine in prediction of the success of radiofrequency ablation in Wolff-Parkinson-White syndrome].
    Tebbenjohanns J; Pfeiffer D; Jung W; Manz M; Lüderitz B
    Z Kardiol; 1994 Feb; 83(2):173-7. PubMed ID: 8165849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiologic characteristics and radiofrequency catheter ablation in children with Wolff-Parkinson-White syndrome.
    Lee PC; Hwang B; Chen YJ; Tai CT; Chen SA; Chiang CE
    Pacing Clin Electrophysiol; 2006 May; 29(5):490-5. PubMed ID: 16689844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of continuous enhanced vagal tone on dual atrioventricular node and accessory pathways.
    Chiou CW; Chen SA; Kung MH; Chang MS; Prystowsky EN
    Circulation; 2003 May; 107(20):2583-8. PubMed ID: 12743004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.